high
Sell
50,500 shares
$911,842
Significance
6/10
COO Ryan Cohlhepp sold 50,500 shares at $18.06 across 4 transactions for $911,841.99
Ryan Cohlhepp, President and COO of Bicara Therapeutics, executed 4 separate sales totaling 50,500 shares for $911,841.99, reducing his holdings from 253.1K shares to 202.6K shares (-19.9%). The company is unprofitable with net income of $-27,388,000.00 over its most recent full fiscal year. The stock has risen 81.4% over 90 days and 46.5% over 30 days, trading at $18.00 near the midpoint of its 52-week range ($8.71–$25.19). The sale by a C-level executive during a period of significant stock appreciation in an unprofitable company warrants monitoring of broader insider activity and forward guidance.